Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

1.

Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome.

Streeck H, Lu R, Beckwith N, Milazzo M, Liu M, Routy JP, Little S, Jessen H, Kelleher AD, Hecht F, Sekaly RP, Alter G, Heckerman D, Carrington M, Rosenberg ES, Altfeld M.

J Virol. 2014 Aug 27. pii: JVI.02016-14. [Epub ahead of print]

PMID:
25165102
[PubMed - as supplied by publisher]
2.

IL-10 and lymphotoxin-α expression profiles within marginal zone-like B-cell populations are associated with control of HIV-1 disease progression.

Chagnon-Choquet J, Fontaine J, Poudrier J, Roger M; Montreal Primary HIV Infection Study Group; Slow Progressor Study Group.

PLoS One. 2014 Jul 8;9(7):e101949. doi: 10.1371/journal.pone.0101949. eCollection 2014.

PMID:
25003989
[PubMed - in process]
Free PMC Article
3.

Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study.

Papuchon J, Pinson P, Guidicelli GL, Bellecave P, Thomas R, LeBlanc R, Reigadas S, Taupin JL, Baril JG, Routy JP, Wainberg M, Fleury H; Provir/Latitude 45 study group.

PLoS One. 2014 Jun 25;9(6):e100452. doi: 10.1371/journal.pone.0100452. eCollection 2014.

PMID:
24964202
[PubMed - in process]
Free PMC Article
4.

Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Jenabian MA, Patel M, Kema I, Vyboh K, Kanagaratham C, Radzioch D, Thébault P, Lapointe R, Gilmore N, Ancuta P, Tremblay C, Routy JP.

Clin Exp Immunol. 2014 Oct;178(1):102-11. doi: 10.1111/cei.12396.

PMID:
24924152
[PubMed - in process]
5.

Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.

Routy JP, Angel J, Patel M, Kanagaratham C, Radzioch D, Kema I, Gilmore N, Ancuta P, Singer J, Jenabian MA.

HIV Med. 2014 Jun 2. doi: 10.1111/hiv.12171. [Epub ahead of print]

PMID:
24889179
[PubMed - as supplied by publisher]
6.

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee.

J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844.

PMID:
24870935
[PubMed - in process]
Free Article
7.

A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.

Jacobson JM, Wang H, Bordi R, Zheng L, Gross BH, Landay AL, Spritzler J, Routy JP, Benson C, Aberg J, Tebas P, Haas DW, Tiu J, Coughlin K, Purdue L, Sekaly RP; AIDS Clinical Trials Group (ACTG) A5212 Protocol Team.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):399-406. doi: 10.1097/QAI.0000000000000195.

PMID:
24815851
[PubMed - indexed for MEDLINE]
8.

HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2.

Pham TN, Lukhele S, Hajjar F, Routy JP, Cohen ÉA.

Retrovirology. 2014 Feb 6;11:15. doi: 10.1186/1742-4690-11-15.

PMID:
24498878
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.

Sereti I, Estes JD, Thompson WL, Morcock DR, Fischl MA, Croughs T, Beq S, Lafaye de Micheaux S, Yao MD, Ober A, Wilson EM, Natarajan V, Imamichi H, Boulassel MR, Lederman MM, Routy JP.

PLoS Pathog. 2014 Jan 30;10(1):e1003890. doi: 10.1371/journal.ppat.1003890. eCollection 2014 Jan.

PMID:
24497828
[PubMed - in process]
Free PMC Article
10.

CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission.

Li Y, Han Y, Xie J, Gu L, Li W, Wang H, Lv W, Song X, Li Y, Routy JP, Ishida T, Iwamoto A, Li T; CACT0810 group.

AIDS. 2014 Feb 20;28(4):521-30. doi: 10.1097/QAD.0000000000000125.

PMID:
24472744
[PubMed - indexed for MEDLINE]
11.

HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.

Song R, Lisovsky I, Lebouché B, Routy JP, Bruneau J, Bernard NF.

PLoS Pathog. 2014 Jan;10(1):e1003867. doi: 10.1371/journal.ppat.1003867. Epub 2014 Jan 16.

PMID:
24453969
[PubMed - in process]
Free PMC Article
12.

Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.

Cuerquis J, Romieu-Mourez R, François M, Routy JP, Young YK, Zhao J, Eliopoulos N.

Cytotherapy. 2014 Feb;16(2):191-202. doi: 10.1016/j.jcyt.2013.11.008.

PMID:
24438900
[PubMed - indexed for MEDLINE]
13.

Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication.

Bernier A, Cleret-Buhot A, Zhang Y, Goulet JP, Monteiro P, Gosselin A, DaFonseca S, Wacleche VS, Jenabian MA, Routy JP, Tremblay C, Ancuta P.

Retrovirology. 2013 Dec 21;10:160. doi: 10.1186/1742-4690-10-160.

PMID:
24359430
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection.

Vaidya SA, Streeck H, Beckwith N, Ghebremichael M, Pereyra F, Kwon DS, Addo MM, Rychert J, Routy JP, Jessen H, Kelleher AD, Hecht F, Sekaly RP, Carrington M, Walker BD, Allen TM, Rosenberg ES, Altfeld M.

Retrovirology. 2013 Nov 18;10:139. doi: 10.1186/1742-4690-10-139.

PMID:
24245727
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions.

Rodrigues-Coutlée C, Archambault J, Money D, Ramanakumar AV, Raboud J, Hankins C, Koushik A, Richardson H, Brassard P, Franco EL, Coutlée F; Canadian Women's HIV Study Group.

J Clin Virol. 2013 Dec;58(4):660-5. doi: 10.1016/j.jcv.2013.10.015. Epub 2013 Oct 17.

PMID:
24210329
[PubMed - indexed for MEDLINE]
16.

Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers.

Jenabian MA, Patel M, Kema I, Kanagaratham C, Radzioch D, Thébault P, Lapointe R, Tremblay C, Gilmore N, Ancuta P, Routy JP.

PLoS One. 2013 Oct 16;8(10):e78146. doi: 10.1371/journal.pone.0078146. eCollection 2013.

PMID:
24147117
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Impact of autologous dendritic cell-based immunotherapy (AGS-004) on B- and T-cell subset changes and immune activation in HIV-infected patients receiving antiretroviral therapy.

Jenabian MA, Nicolette CA, Tcherepanova IY, Debenedette MA, Gilmore N, Routy JP.

J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):345-50. doi: 10.1097/QAI.0b013e3182a4b9ad.

PMID:
24025338
[PubMed - indexed for MEDLINE]
18.

The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication.

Clerzius G, Shaw E, Daher A, Burugu S, Gélinas JF, Ear T, Sinck L, Routy JP, Mouland AJ, Patel RC, Gatignol A.

Retrovirology. 2013 Sep 11;10:96. doi: 10.1186/1742-4690-10-96.

PMID:
24020926
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection.

Breton G, Chomont N, Takata H, Fromentin R, Ahlers J, Filali-Mouhim A, Riou C, Boulassel MR, Routy JP, Yassine-Diab B, Sékaly RP.

J Immunol. 2013 Sep 1;191(5):2194-204. doi: 10.4049/jimmunol.1200646. Epub 2013 Aug 5.

PMID:
23918986
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

French HIV experts on early antiretroviral treatment for prevention: uncertainty and heterogeneity.

Lebouché B, Engler K, Lévy JJ, Gilmore N, Spire B, Rozenbaum W, Lacene T, Routy JP.

J Int Assoc Provid AIDS Care. 2014 Mar-Apr;13(2):160-9.

PMID:
23761218
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk